Physician

Kevin Roy Swan, M.D.

According to 2025 Medicare claims, Kevin Swan, M.D. (NPI: 1215112578) practices ophthalmology in the Lafayette, LA market, with the plurality of this provider's patient population coming from Lafayette, LA. This provider's primary affiliated billing organization is JOSEPH & SWAN EYE CENTER, A PROFESSIONAL MEDICAL CORPORATION (NPI: 1356344790; TIN: 72-0795996) and primary practice location at 70503-2460.

Swan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,030 traditional Medicare patients, billed 3,160 HCPCS/CPT codes, and received $474,027 in Medicare payments. The top billing code was 66984 (Removal of cataract with insertion of prosthetic lens). Part D data shows 1,338 prescription claims across 268 beneficiaries totaling $458,943 in drug costs, led by Oxervate (Cenegermin-Bkbj). DME data shows 30 claims. Open Payments data shows 18 records totaling $550. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $162,185 to $458,943. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	795	2,614	$359,628
2016	894	2,808	$370,348
2017	1,112	3,304	$440,671
2018	1,278	3,869	$516,431
2019	1,214	3,677	$479,113
2020	1,056	3,114	$382,270
2021	1,069	3,434	$459,451
2022	993	3,239	$452,631
2023	1,005	2,962	$459,149
2024	1,030	3,160	$474,027

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	321	1,308	$162,185
2016	323	1,473	$156,551
2017	464	1,762	$190,832
2018	619	2,437	$217,876
2019	542	2,337	$209,210
2020	547	2,419	$213,320
2021	485	2,300	$294,484
2022	245	1,385	$449,131
2023	244	1,329	$401,975
2024	268	1,338	$458,943

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	13	13	$834
2016	60	61	$3,908
2017	28	28	$1,295
2018	53	53	$3,590
2019	40	40	$2,047
2020	N/R	N/R	N/R
2021	11	11	$558
2022	42	42	$2,409
2023	N/R	N/R	N/R
2024	30	30	$2,154

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
66984	Removal of cataract with insertion of prosthetic lens	543	900	$348
92004	New patient complete exam of visual system	411	411	$91
92014	Established patient complete exam of visual system	221	229	$72
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	184	411	$60
92136	Measurement of corneal curvature and depth of eye	412	678	$26

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Oxervate	Cenegermin-Bkbj	12	168	$340,948
Restasis	Cyclosporine	49	2,130	$41,501
Prednisolone Acetate	Prednisolone Acetate	274	13,380	$16,448
Fluorometholone	Fluorometholone	119	6,263	$10,405
Cyclosporine	Cyclosporine	18	854	$4,407

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
V2200	Sphere, bifocal, plano to plus or minus 4.00d, per lens	N	13	13	$1,183
V2020	Frames, purchases	N	17	17	$971

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	18	$550	Alcon Vision LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Kevin Roy Swan, M.D.?

Tedicare shows public-source Medicare data for Kevin Roy Swan, M.D. (NPI 1215112578), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kevin Roy Swan, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Kevin Roy Swan, M.D.?

Kevin Roy Swan, M.D. is linked to JOSEPH & SWAN EYE CENTER, A PROFESSIONAL MEDICAL CORPORATION (billing NPI 1356344790) in the available physician profile data.

Does Kevin Roy Swan, M.D. have Open Payments data?

Kevin Roy Swan, M.D. has 18 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.